This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
A new review unifies diagnosis, surgery, and emerging therapies for childhood neuroblastoma into one risk-guided framework. With survival below 60% for high-risk cases, personalized, multimodal care has never been more critical. #Neuroblastoma #PediatricOncology
2026-08-08T08:02:06.270Z